CNTX 8-K: SEC filing
Context Therapeutics
Filed with the SEC on · accession 0001628280-26-072768
CNTX filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -5.7% by the first close after the filing.
Summary of the filing
Context Therapeutics issued a press release announcing its third quarter 2026 operating and financial results and provided pipeline progress updates, along with an updated corporate presentation.
Key details
How CNTX stock reacted
Close before
$0.20
Nov 9, 2026
First close after
-5.74%
$0.19
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CNTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CNTX?
Click hereFrequently asked questions
What did CNTX file with the SEC on Nov 10, 2026?
CNTX filed a 8-K (SEC filing). Context Therapeutics issued a press release announcing its third quarter 2026 operating and financial results and provided pipeline progress updates, along with an updated corporate presentation.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did CNTX stock react to this filing?
CNTX closed at $0.20 before the filing and $0.19 on Nov 10, 2026 (-5.74%).
Other CNTX SEC filings
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
- 8-K · Delisting noticeJul 31, 2026
- 8-K · SEC filingJun 26, 2026
- 8-K · Fda approvalJun 15, 2026
- 8-K · Material agreementMay 18, 2026
- 10-Q · SEC filingMay 6, 2026
- 8-K · Legal settlementMay 1, 2026
Get alerts when CNTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days